- Home
- RETO vs CYCN Comparison
RETO vs CYCN Comparison
Compare RETO & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RETO
- CYCN
- Stock Information
- Founded
- RETO 1999
- CYCN 2018
- Country
- RETO China
- CYCN United States
- Employees
- RETO N/A
- CYCN N/A
- Industry
- RETO Multi-Sector Companies
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- RETO Consumer Discretionary
- CYCN Health Care
- Exchange
- RETO Nasdaq
- CYCN Nasdaq
- Market Cap
- RETO 7.3M
- CYCN 7.6M
- IPO Year
- RETO 2017
- CYCN N/A
- Fundamental
- Price
- RETO $2.57
- CYCN $1.47
- Analyst Decision
- RETO
- CYCN
- Analyst Count
- RETO 0
- CYCN 0
- Target Price
- RETO N/A
- CYCN N/A
- AVG Volume (30 Days)
- RETO 18.2K
- CYCN 1.1M
- Earning Date
- RETO 05-05-2026
- CYCN 11-12-2025
- Dividend Yield
- RETO N/A
- CYCN N/A
- EPS Growth
- RETO N/A
- CYCN N/A
- EPS
- RETO N/A
- CYCN N/A
- Revenue
- RETO $2,109,956.00
- CYCN $2,855,000.00
- Revenue This Year
- RETO N/A
- CYCN N/A
- Revenue Next Year
- RETO N/A
- CYCN N/A
- P/E Ratio
- RETO N/A
- CYCN N/A
- Revenue Growth
- RETO 16864.81
- CYCN 1371.65
- 52 Week Low
- RETO $2.50
- CYCN $1.28
- 52 Week High
- RETO $61.50
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- RETO 56.51
- CYCN 38.64
- Support Level
- RETO $2.66
- CYCN $1.33
- Resistance Level
- RETO $2.86
- CYCN $1.50
- Average True Range (ATR)
- RETO 0.19
- CYCN 0.16
- MACD
- RETO -0.05
- CYCN 0.00
- Stochastic Oscillator
- RETO 11.48
- CYCN 20.00
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation, and construction of urban ecological environments for capturing, controlling, and reusing rainwater. It operates through two segments, namely Machinery and Equipment sales, and Technology Consulting and other services. The company earns its revenue from the Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.